Parexel Baltimore EPCU — Baltimore, Maryland

Parexel Baltimore EPCU is a clinical research site located in Baltimore, Maryland, United States 21225.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Parexel Baltimore EPCU has participated in 1 clinical trials.

Therapeutic areas: Molybdenum Cofactor Deficiency (MoCD), Rare Autosomal Recessive Disorder, Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase).

Sponsors: Origin Biosciences.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Parexel Baltimore EPCU?

Parexel Baltimore EPCU has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Parexel Baltimore EPCU conducted?

Parexel Baltimore EPCU has 1 clinical trials on record. Their work covers Molybdenum Cofactor Deficiency (MoCD), Rare Autosomal Recessive Disorder, Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase).

Is Parexel Baltimore EPCU accredited by Crixeo Health?

Parexel Baltimore EPCU has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Parexel Baltimore EPCU?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.